logo
PathAI and Moffitt Cancer Center Announce Strategic Collaboration to Deploy the AISight® Dx Digital Pathology Platform and Advance AI Diagnostics

PathAI and Moffitt Cancer Center Announce Strategic Collaboration to Deploy the AISight® Dx Digital Pathology Platform and Advance AI Diagnostics

Associated Press4 hours ago
BOSTON, Mass., and TAMPA, Fla., Aug. 21, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in artificial intelligence and digital pathology solutions, and Moffitt Cancer Center, one of the nation's top cancer hospitals and a leader in cancer research, today announced a multi-year strategic collaboration to deploy PathAI's digital pathology platform, AISight® Dx, across Moffitt's pathology programs to transform cancer detection and innovation.
AISight® Dx, is PathAI's cloud-native digital pathology image management system designed to support both laboratory workflow and translational research use cases. It combines enterprise-scale slide management, viewing, and collaboration with seamless AI integration, driving scalable pathology operational efficiencies and enhanced speed and accuracy. The partnership also establishes a framework for joint research programs, collation of real-world multimodal data, initiatives to support clinical trials and biopharma collaborations, and the co-development of next-generation AI-based diagnostics to enhance precision medicine.
'We are thrilled to partner with Moffitt Cancer Center, an institution renowned for its commitment to innovation and excellence in cancer care,' said Andy Beck, MD, PhD, CEO and Co-Founder of PathAI. 'By deploying AISight ® Dx and building this strategic partnership, we're equipping Moffitt's pathologists and researchers with cutting-edge tools to support diagnosis, streamline operations, and unlock novel insights from pathology data.'
'This collaboration aligns perfectly with Moffitt's mission to contribute to the prevention and cure of cancer through transformative care, cutting-edge science and innovation,' said Karen Lu, MD, executive vice president and physician-in-chief at Moffitt Cancer Center. 'By deploying AISight® Dx into our pathology infrastructure, we're taking a significant step forward in the integration of AI-driven technology into clinical oncology, enabling faster, more accurate pathologist review.
'Adopting cutting-edge digital pathology technologies is key to driving Moffitt's vision for a true digital transformation, one that unlocks a wealth of pathology data and seamlessly integrates it with imaging and clinical insights to deliver truly personalized patient care,' said William Westra, MD, vice chair of Pathology at Moffitt Cancer Center. 'By partnering with PathAI, we're laying the groundwork for next-generation oncology research that will shape future AI-powered care models, while building on PathAI's and Moffitt's legacy of advancing cancer pathology, innovative therapies, and breakthrough diagnostics.'
Together, PathAI and Moffitt Cancer Center aim to redefine the role of digital pathology and AI in cancer care, setting a precedent for how cutting-edge technologies and clinical expertise can converge to drive meaningful improvements in pathology.
For more information about PathAI, or AISight Dx, please contact [email protected] or visit pathai.com.
1 AISight® is for Research Use Only in the US; AISight® Dx is FDA-cleared for primary diagnosis in the US, and is CE‑IVD–marked for primary diagnosis in the EEA, UK, and Switzerland.
About PathAI
PathAI is a leading provider of integrated AI and digital pathology solutions dedicated to transforming workflow and operational efficiency in pathology labs worldwide. Through innovative technologies and strategic partnerships, PathAI aims to enhance patient outcomes and drive the future of medical diagnostics. For more information, visit www.pathai.com.
About Moffitt Cancer Center
Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 57 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt's scientific excellence, multidisciplinary research, and robust training and education. Moffitt's expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, X, Instagram and YouTube.
Company Contact
Liz Storti
Chief People Officer
[email protected]
Media Contact
Owen Blaschak
LifeSci Communications
[email protected]
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How major US stock indexes fared Thursday, 8/21/2025
How major US stock indexes fared Thursday, 8/21/2025

Yahoo

time10 minutes ago

  • Yahoo

How major US stock indexes fared Thursday, 8/21/2025

Wall Street fell to a fifth straight loss. The S&P 500 slipped 0.4% Thursday. The Dow Jones Industrial Average dropped 152 points, and the Nasdaq composite fell 0.3%. Walmart weighed on the market after delivering a weaker-than-expected profit report for the spring, while Nvidia and other Big Tech stocks held a bit steadier following two days of sharp swings. Treasury yields rose after a report on U.S. business activity dampened Wall Street's hopes for coming cuts to interest rates. All the S&P 500's losses have been relatively modest, but it has not risen since setting an all-time high last Thursday. On Thursday: The S&P 500 fell 25.61 points, or 0.4%, to 6,370.17 The Dow Jones Industrial Average fell 152.81 points, or 0.3%, to 44,785.50. The Nasdaq composite fell 72.55 points, or 0.7%, to 21,100.31. The Russell 2000 index of smaller companies rose 4.74 points, or 0.2%, to 2,274.10. For the week: The S&P 500 is down 79.63 points, or 1.2%. The Dow is down 160.62 points, or 0.4%. The Nasdaq is down 522.66 points, or 2.4%. The Russell 2000 is down 12.43 points, or 0.5%. For the year: The S&P 500 is up 488.54 points, or 8.3%. The Dow is up 2,341.28 points, or 5.3%. The Nasdaq is up 1,789.52 points, or 9.3%. The Russell 2000 is up 43.94 points, or 2%. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Lincoln Electric Announces September 2025 Events with the Financial Community
Lincoln Electric Announces September 2025 Events with the Financial Community

Yahoo

time10 minutes ago

  • Yahoo

Lincoln Electric Announces September 2025 Events with the Financial Community

CLEVELAND, August 21, 2025--(BUSINESS WIRE)--Lincoln Electric Holdings, Inc., (Nasdaq: LECO) today announced participation in the following upcoming events with the financial community in the month of September: Jefferies Industrials ConferenceThursday, September 4, 20258:50 am ET live webcastNew York, NYGabe Bruno, Executive Vice President and Chief Financial Officer Morgan Stanley 13th Annual Laguna ConferenceThursday, September 11, 20259:15 am PT (12:15 pm ET) live webcastDana Point, CAGabe Bruno, Executive Vice President and Chief Financial Officer Webcasts and replays can be accessed on our Investor Relations web site: About Lincoln Electric Lincoln Electric is the world leader in the engineering, design, and manufacturing of advanced arc welding solutions, automated joining, assembly and cutting systems, plasma and oxy-fuel cutting equipment, and has a leading global position in brazing and soldering alloys. Lincoln is recognized as the Welding Expert™ for its leading materials science, software development, automation engineering, and application expertise, which advance customers' fabrication capabilities to help them build a better world. Headquartered in Cleveland, Ohio, Lincoln has 71 manufacturing locations in 20 countries and a worldwide network of distributors and sales offices serving customers in over 160 countries. For more information about Lincoln Electric and its products and services, visit the Company's website at View source version on Contacts Amanda ButlerVice President, Investor Relations & CommunicationsTel: 216.383.2534Email: Amanda_Butler@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

WM CFO Devina Rankin to Retire David Reed to Succeed Rankin
WM CFO Devina Rankin to Retire David Reed to Succeed Rankin

Yahoo

time10 minutes ago

  • Yahoo

WM CFO Devina Rankin to Retire David Reed to Succeed Rankin

HOUSTON, August 21, 2025--(BUSINESS WIRE)--WM (NYSE: WM) announced that Devina Rankin, executive vice president and chief financial officer, is planning to retire. After nearly 23 successful years with the company, Rankin has decided to dedicate focus to her long-standing passions for education and not-for-profit service. She will transition out of the CFO role in November 2025 and will remain as an executive advisor to ensure an effective transition through March 2026. "Devina has been an invaluable contributor to WM's successes over the years, whether it be collaborating to deliver impressive financial results or evolving our strategy and culture to focus on growth, technology, sustainability, and our core values," said Jim Fish, chief executive officer. "As a passionate, driven, and people-centric leader, she has played an incredibly important role on WM's senior leadership team since becoming CFO in 2017. Devina's eight and a half years with me as CFO and CEO have been hugely impactful to me, to our company, and to our shareholders. I know Devina is excited to take this next big step in her life, and I have no doubt that she will be successful." David Reed will succeed Rankin as executive vice president and CFO. Reed, who has been with the company for eight years, is currently vice president and business partner for WM's West Tier operations and before that served as the company's vice president and treasurer. He brings extensive finance and leadership experience to the role with a background that includes investment banking, investor relations, corporate finance, treasury, and operations enablement. More information on Reed can be found at "David is a well-respected leader known for his strategic thinking, discipline, and partnership," said Fish. "He has been a valuable member of the WM finance and operations teams, and we are confident in his ability to scale his impact as we focus on WM's long-term growth." ABOUT WM WM ( is North America's leading provider of comprehensive environmental solutions. Previously known as Waste Management and based in Houston, Texas, WM is driven by commitments to put people first and achieve success with integrity. The company, through its subsidiaries, provides collection, recycling and disposal services to millions of residential, commercial, industrial, medical and municipal customers throughout the U.S. and Canada. With innovative infrastructure and capabilities in recycling, organics and renewable energy, WM provides environmental solutions to and collaborates with its customers in helping them pursue their sustainability goals. In North America, WM has the largest disposal network and collection fleet, is the largest recycler and is a leader in beneficial use of landfill gas, with a growing network of renewable natural gas plants and the most landfill gas-to-electricity plants, as well as the largest heavy-duty natural gas truck fleet in the industry. WM Healthcare Solutions provides collection and disposal services of regulated medical waste and secure information destruction services in the U.S., Canada and Western Europe. To learn more about WM and the company's sustainability progress and solutions, visit View source version on Contacts FOR MORE INFORMATION WM Website Analysts Ed Egl713.265.1656eegl@ Media Toni Wernermedia@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store